Anti-CD154 monoclonal antibody and thromboembolism

被引：38

作者：

Buhler, L ^{[1
]}

Alwayn, IPJ

Appel, JZ

Robson, SC

Cooper, DKC

机构：

[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Transplantat Biol Res Ctr, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Immunobiol, Boston, MA 02115 USA

来源：

TRANSPLANTATION | 2001年 / 71卷 / 03期

关键词：

D O I：

10.1097/00007890-200102150-00028

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：491 / 491

页数：1

共 5 条

[1]

Bühler L, 2000, TRANSPLANTATION, V70, P1323

[2]

Bühler L, 2000, TRANSPLANTATION, V69, P2296

[3]

Kawai T, 2000, NAT MED, V6, P114, DOI 10.1038/72162

[4]

Kirk AD, 2000, NAT MED, V6, P114, DOI 10.1038/72164

[5] Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates [J].

Kirk, AD ;

Burkly, LC ;

Batty, DS ;

Baumgartner, RE ;

Berning, JD ;

Buchanan, K ;

Fechner, JH ;

Germond, RL ;

Kampen, RL ;

Patterson, NB ;

Swanson, SJ ;

Tadaki, DK ;

TenHoor, CN ;

White, L ;

Knechtle, SJ ;

Harlan, DM .

NATURE MEDICINE, 1999, 5 (06) :686-693

← 1 →